Literature DB >> 15715084

Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis.

Allan J Bieber1, Daren R Ure, Moses Rodriguez.   

Abstract

For reasons that are not well understood, central nervous system repair in multiple sclerosis is often minimal. We present evidence, in a murine model of chronic progressive multiple sclerosis, that genetic factors can substantially influence remyelination, axonal integrity, and neurologic function. Four inbred mouse strains, SJL, B10.D1-H2(q), FVB, and SWR, developed extensive inflammatory demyelination by 3 months after infection with Theiler's murine encephalomyelitis virus. Demyelination continued lifelong in SJL and B10.D1-H2(q) mice, accompanied by axonal injury, minimal remyelination, and progressive motor dysfunction. In contrast, FVB and SWR mice showed less axonal injury, progressive remyelination, and stabilization of motor function. Genetic dominance of the reparative traits was demonstrated by crossing remyelinating strains (FVB and SWR) with nonremyelinating strains (SJL and B10.D1-H2(q)). All F1 mice developed a phenotype identical to FVB and SWR, showing extensive remyelination, partial preservation of axons, and preserved motor function. Analyses of viral RNA and antigen, immune cell infiltration, and antiviral antibody titers did not predict the phenotypic differences between strains. These results highlight the significant extent to which hereditary factors can control disease course and demonstrate that the switch from a pathogenic to a reparative phenotype can occur even after prolonged inflammatory demyelination.

Entities:  

Mesh:

Year:  2005        PMID: 15715084     DOI: 10.1093/jnen/64.1.46

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  14 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

2.  Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Laurie Zoecklein; Moses Rodriguez
Journal:  J Neurol Transl Neurosci       Date:  2014-01

3.  Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis.

Authors:  Aleksandar Denic; Istvan Pirko; Bharath Wootla; Allan Bieber; Slobodan Macura; Moses Rodriguez
Journal:  Brain Pathol       Date:  2012-03-08       Impact factor: 6.508

Review 4.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

5.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

6.  Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.

Authors:  Allan J Bieber; Kanitta Suwansrinon; Jason Kerkvliet; Weidong Zhang; Larry R Pease; Moses Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

7.  Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord.

Authors:  Aleksandar Denic; Allan Bieber; Arthur Warrington; Prasanna K Mishra; Slobodan Macura; Moses Rodriguez
Journal:  Ann Neurol       Date:  2009-10       Impact factor: 10.422

Review 8.  Experimental and therapeutic opportunities for stem cells in multiple sclerosis.

Authors:  Rickie Patani; Siddharthan Chandran
Journal:  Int J Mol Sci       Date:  2012-11-08       Impact factor: 5.923

9.  A monoclonal natural human IgM protects axons in the absence of remyelination.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  J Neuroinflammation       Date:  2016-04-28       Impact factor: 8.322

Review 10.  Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.

Authors:  Bharath Wootla; Aleksandar Denic; Jens O Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Mol Neurobiol       Date:  2015-09-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.